 |
|
Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):623-642. Published online 2023 Feb 20 DOI: https://doi.org/10.3350/cmh.2022.0349
|
|
Citations to this article as recorded by
 Acute Hepatitis C as an Acute Cause of Acute-on-chronic Liver Failure in Alcohol-associated Liver Disease
Narendra S. Choudhary, Kunwar A. Singh, Swapnil Dhampalwar, Neeraj Saraf, Virendra Singh
Journal of Clinical and Experimental Hepatology.2025; 15(1): 102423. CrossRef Nanodiagnostics in global eradication of hepatitis C virus
Mohammad Darvishi, Reza Amiri, Emad Ghannad, Samir Mehrabkhani, Nassim Rastgar, Mahkameh Razaghi, Jaya Bansal, Mamata Chahar, Pranchal Rajput, Hossein Saffarfar, Payam Ali-Khiavi, Ahmad Mobed, Yalda Yazdani
Clinica Chimica Acta.2025; 565: 120013. CrossRef Prevalence and drug resistance analysis of hepatitis C virus genotypes in Heilongjiang, China
Bo Du, Le Yu, Kun Zhou, Han Qiao, Meng Wu, Dong Wang, Xi Jin, Jing Feng, Xingku Li, Rongzheng Zhang, Shuyun Zhang
Infection, Genetics and Evolution.2025; 127: 105700. CrossRef Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients
Gantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, Dolgion Daramjav, Enkhmend Khayankhyarvaa, Bolor Ulziitsogt, Otgongerel Nergui, Ganchimeg Dondov, Tegshjargal Badamjav, Tulgaa Lonjid, Chung-Feng Huang, Po-Cheng Liang, Batbold Batsaikha
Diseases.2025; 13(2): 26. CrossRef Southeast Asia burden and trend of Gastrointestinal tract cancers from 1990 to 2021 and its prediction to 2050: findings from the Global Burden of Disease Study 2021
Duanyu Wang, Minghao Tan, Pengkhun Nov
International Journal of Colorectal Disease.2025;[Epub] CrossRef Nanoparticle-based biosensor integrated with multiple cross-displacement amplification for visual and rapid identification of hepatitis B virus and hepatitis C virus
Hang Zhang, Yuanfang Shi, Zengguang Wu, Qi Zhao, Yu Wang, Xinggui Yang, Yan Tan, Yi Wang, Zhenghua Xiao, Xu Chen, Anne Piantadosi
Microbiology Spectrum.2025;[Epub] CrossRef Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer
Lirui Tang, Haiying Que, Yuquan Wei, Ting Yang, Aiping Tong, Xiawei Wei
Journal of Hematology & Oncology.2025;[Epub] CrossRef Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury
Shu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, Kuang-Tzu Huang, Li-Wen Hsu, Hock-Liew Eng, King-Wah Chiu
Antibodies.2024; 13(1): 7. CrossRef Direct-Acting Antiviral Treatment for Acute Hepatitis C in Japanese Patients: Clinical Course and Outcomes
Hiroshi Okano, Katsumi Mukai, Akira Nishimura
Cureus.2024;[Epub] CrossRef Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children
Chaowapong Jarasvaraparn, Christopher Hartley, Wikrom Karnsakul
Pathogens.2024; 13(2): 180. CrossRef Improving HCV diagnosis following a false-negative anti-HCV result
Xia Long, Yu Chen, Minggang Yin, Weiping Liu
Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(10): e229. CrossRef Toward hepatitis C virus elimination using artificial intelligence
Moon Haeng Hur, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2024; 30(2): 147. CrossRef Una visión integral del manejo de la hepatitis C y el objetivo de erradicarla
Juan Carlos Restrepo-Gutiérrez
Hepatología.2024; 5(2): 120. CrossRef Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
Malik Sallam, Roaa Khalil
Microorganisms.2024; 12(6): 1035. CrossRef Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals
Chen‐Hua Liu, Yu‐Ping Chang, Ji‐Yuh Lee, Chi‐Yi Chen, Wei‐Yu Kao, Chih‐Lin Lin, Sheng‐Shun Yang, Yu‐Lueng Shih, Cheng‐Yuan Peng, Fu‐Jen Lee, Ming‐Chang Tsai, Shang‐Chin Huang, Tung‐Hung Su, Tai‐Chung Tseng, Chun‐Jen Liu, Pei‐Jer Chen, Jia‐Horng Kao
Journal of Medical Virology.2024;[Epub] CrossRef Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review
Dario Di Stasio, Agostino Guida, Antonio Romano, Massimo Petruzzi, Aldo Marrone, Fausto Fiori, Alberta Lucchese
Journal of Clinical Medicine.2024; 13(14): 4012. CrossRef An ultrasensitive fluorescence sensing platform for HCV detection based on the T7 isothermal amplification combined with aggregation-induced emission luminogens strategy
Wuxiu Guo, Xin Zhu, Jinchao Li, Linhai Li
Sensors and Actuators Reports.2024; 8: 100229. CrossRef The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection
Justyna Żychowska, Maciej Ćmil, Patryk Skórka, Joanna Olejnik-Wojciechowska, Paulina Plewa, Estera Bakinowska, Kajetan Kiełbowski, Andrzej Pawlik
Biomolecules.2024; 14(8): 986. CrossRef Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review
Chen-Hua Liu, Yu-Ping Chang, Jia-Horng Kao
Expert Opinion on Pharmacotherapy.2024; 25(12): 1691. CrossRef Acute Hepatitis C: Current Status and Future Perspectives
Massimo Fasano, Francesco Ieva, Marianna Ciarallo, Bruno Caccianotti, Teresa Antonia Santantonio
Viruses.2024; 16(11): 1739. CrossRef Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model
Andrea Mambro, Sameh Mortazhejri, David Ortiz-Paredes, Andrea Patey, Guillaume Fontaine, Camille Dussault, Joseph Cox, Jeremy M. Grimshaw, Justin Presseau, Nadine Kronfli
Viruses.2024; 16(12): 1910. CrossRef Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation
Rebecca A Dieter, Aprajita Mattoo, Perry Hotchkis, Ian S Jaffe, Elaina P Weldon, Jonathan C Berger, Nicole M Ali, Robert A Montgomery, Bonnie E Lonze
Nephrology Dialysis Transplantation.2024;[Epub] CrossRef Safety considerations in the management of hepatitis C and HIV co-infection
Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Pablo Barreiro, Fernando de Jesus, Octavio Corral, Carmen de Mendoza
Expert Opinion on Drug Safety.2023; 22(5): 363. CrossRef Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials
Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari
Arabian Journal of Chemistry.2023; 16(8): 105013. CrossRef Oryza sativa L. Indica Seed Coat Ameliorated Concanavalin A—Induced Acute Hepatitis in Mice via MDM2/p53 and PKCα/MAPK1 Signaling Pathways
Zhiye Zhao, Ye Li, Shancheng Guo, Yuxu Chen, Haiaolong Yin, Yaxian Li, Guiguang Cheng, Lei Tian
International Journal of Molecular Sciences.2023; 24(19): 14503. CrossRef Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina
Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation.2023; 13(4): 519. CrossRef A Synopsis of Hepatitis C Virus Treatments and Future Perspectives
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis
Current Issues in Molecular Biology.2023; 45(10): 8255. CrossRef
|